Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM) Meeting Abstract
| Authors: | Carvajal, R. D.; Sato, T.; Butler, M. O.; Sacco, J. J.; Shoushtari, A. N.; Hassel, J. C.; Ikeguchi, A.; Hernandez-Aya, L. F.; Rioth, M.; Hamid, O.; Piulats, J. M.; Luke, J. J.; Johnson, D. B.; Leyvraz, S.; Espinosa, E.; Collins, L.; McCully, M. L.; Lockwood, S.; Abdullah, S. E.; Nathan, P. |
| Abstract Title: | Characterization of cytokine release syndrome (CRS) following treatment with tebentafusp in patients (pts) with previously treated (2L+) metastatic uveal melanoma (mUM) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120605133 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.9531 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9531 -- Source: Wos |
